Tulpule Lab @tulpulelab.bsky.social · 26/11/2024Thanks Anton! Important question - my view is that fusion-induced replication stress, like PGBD5 expression, likely contribute to the ATR inhibitor responsiveness of ES (mentioned in Discussion), but whether/how RS impairs the physiologic DNA repair response is less clear to me. Curious your view? 010
Tulpule Lab @tulpulelab.bsky.social · 25/11/2024Interested in pediatric cancer and DNA repair? We are recruiting PhD students and postdocs, so please reach out and come join us in NYC. #MSKKids 010
Tulpule Lab @tulpulelab.bsky.social · 25/11/2024We would love to hear feedback, opportunities for new directions and collaborations. This is the work of many at UCSF and MSKCancerCenter, but led by 2 super star postdocs Shruti Menon and Daniel Gracilla. 120
Tulpule Lab @tulpulelab.bsky.social · 25/11/20243. Cell-line and PDX testing of the ATR inhibitor elimusertib as a synthetic lethal therapeutic strategy to target ATM defects across the class of FET rearranged tumors. 100
Tulpule Lab @tulpulelab.bsky.social · 25/11/20242. New mechanistic studies of the interaction/competition between EWSR1-FLI1 (the Ewing fusion) and native FET proteins (i.e., EWSR1) at DNA double-strand breaks. 100
Tulpule Lab @tulpulelab.bsky.social · 25/11/20241. Direct comparison of EWSR1-FLI1’s suppressive effects on ATM activation/signaling with loss of canonical ATM activators to benchmark the effect size and demonstrate the biological significance of the (partial) ATM defects we report here. 100
Tulpule Lab @tulpulelab.bsky.social · 25/11/2024First Bluesky post - a BIG update to our study on Ewing sarcoma and other FET fusion-driven cancers. FET fusion oncoproteins are aberrantly recruited to DNA breaks and cause ATM defects, which can be targeted with the ATR inhibitor elimusertib. Updates include: www.biorxiv.org/content/10.1...biorxiv.org 2121